As presented in Figure 1, in patients with CLD, strongly elevated GH plasma levels and decreased hepatic responsiveness to GH are observed, which result in low IGF1, IGF2, IGFBP3 and ALS plasma levels. The gene discussed is GH1; the disease is amyotrophic lateral sclerosis.